These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 2354287)
21. HTLV-I virus in Europeans: the continuous spread. A meta-analysis. Mayer V; Ebbesen P Acta Virol; 1991 Sep; 35(5):472-95. PubMed ID: 1688082 [TBL] [Abstract][Full Text] [Related]
22. [Antibodies against HTLV-1 in patients undergoing multiple transfusions]. Soriano V; Pauplana M; Ribera A; Tor J; Foz M Rev Clin Esp; 1989 Dec; 185(9):448-50. PubMed ID: 2623278 [TBL] [Abstract][Full Text] [Related]
23. High risk of mother-to-child transmission of HTLV-I in p40tax antibody-positive mothers. Sawada T; Tohmatsu J; Obara T; Koide A; Kamihira S; Ichimaru M; Kashiwagi S; Kajiyama W; Matsumura N; Kinoshita K Jpn J Cancer Res; 1989 Jun; 80(6):506-8. PubMed ID: 2503470 [TBL] [Abstract][Full Text] [Related]
24. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344 [TBL] [Abstract][Full Text] [Related]
25. HTLV infection among Italian intravenous drug users and North African subjects detected by the polymerase chain reaction and serological methods. Colombo E; Magistrelli C; Mendozzi E; Cattaneo E; Achilli G; Ferrante P J Med Virol; 1995 Sep; 47(1):10-5. PubMed ID: 8551251 [TBL] [Abstract][Full Text] [Related]
27. HTLV infections among Swedish intravenous drug users in 1992. Andersson S; Krook A; Käll K; Julander I; Thorstensson R; Biberfeld G Scand J Infect Dis; 1995; 27(6):547-50. PubMed ID: 8685631 [TBL] [Abstract][Full Text] [Related]
28. [HTLV-I antibody screening of blood donors]. Schwarzfischer G; Schätzl H; Bäcker U; Weise W; von der Helm K; Deinhardt F Beitr Infusionsther; 1991; 28():29-31. PubMed ID: 1725641 [TBL] [Abstract][Full Text] [Related]
29. HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group. Soriano V; Calderón E; Esparza B; Cilla G; Aguilera A; Gutiérrez M; Tor J; Pujol E; Merino F; Pérez-Trallero E Int J Epidemiol; 1993 Aug; 22(4):716-9. PubMed ID: 8225748 [TBL] [Abstract][Full Text] [Related]
30. Low seroprevalence of HTLV-I and HTLV-II in patients with a sexually transmitted disease. Study Group for HTLV and STDs. Suligoi B; Galli C; Ciuta S; Decker R Eur J Epidemiol; 1999 Mar; 15(3):225-9. PubMed ID: 10395051 [TBL] [Abstract][Full Text] [Related]
31. Human T-lymphotropic virus (HTLV I-II) infection among patients in an inner-city emergency department. Kelen GD; DiGiovanna TA; Lofy L; Junkins E; Stein A; Sivertson KT; Lairmore M; Quinn TC Ann Intern Med; 1990 Sep; 113(5):368-72. PubMed ID: 2382919 [TBL] [Abstract][Full Text] [Related]
32. [Prevalence of anti-HTLV-I antibodies in intravenous drug addicts in Argentina]. Libonatti O; Lombardi V; Boxaca M; Gertiser R; Muzzio E; Naveira R; Rossi P; Wigzell H; Weissenbacher M Medicina (B Aires); 1989; 49(5):546-7. PubMed ID: 2487427 [No Abstract] [Full Text] [Related]
33. Seroprevalence of human T cell leukaemia/lymphoma virus type I (HTLV-I) in pregnant women, patients attending venereological outpatient services and intravenous drug users from Slovenia. Poljak M; Bednarik J; Rednak K; Seme K; Kristancic L; Celan-Lucu B Folia Biol (Praha); 1998; 44(1):23-5. PubMed ID: 10730871 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) in selected Tijuana subpopulations. Guerena-Burgueno F; Benenson AS; Sepulveda-Amor J; Ascher MS; Vugia DJ; Gallo D Am J Trop Med Hyg; 1992 Aug; 47(2):127-32. PubMed ID: 1503181 [TBL] [Abstract][Full Text] [Related]
35. Risk of HTLV-1 transmission in renal transplantation among aborigines. Moody HR; Thomas MA; Christiansen K; Bucens MR Med J Aust; 1990 Nov; 153(9):564-5. PubMed ID: 2233488 [No Abstract] [Full Text] [Related]
36. [HTLV-I infection in a high-risk group]. Pujol E; Ollero M; Gimeno A; Colchero J; Alcoucer R; Márquez P An Med Interna; 1990 Jul; 7(7):349-52. PubMed ID: 2103246 [TBL] [Abstract][Full Text] [Related]
38. [An epidemiological study of HBV and HTLV-I among high risk groups in Fukuoka City]. Nakashima K; Kashiwagi S; Noguchi A; Hayashi J; Morofuji M; Yamauchi Y; Tokiyama K Kansenshogaku Zasshi; 1990 Apr; 64(4):419-24. PubMed ID: 2401807 [TBL] [Abstract][Full Text] [Related]
39. HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy. Manca N; Caruso A; Bonfanti C; Savoldi E; Li Vigni R; Pirali F; Sapelli PL; Turano A Eur J Epidemiol; 1989 Mar; 5(1):37-41. PubMed ID: 2707393 [TBL] [Abstract][Full Text] [Related]
40. HTLV-I infection in human disease. Spalton DJ; Nicholson F Br J Ophthalmol; 1991 Mar; 75(3):174-5. PubMed ID: 2012786 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]